ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,617.27
0.81%
US Tech 100
19,124.58
1.38%
다우존스 지수
41,473.57
0.10%
Bitcoin
82,639.98
-0.25%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Chimerix Inc (CMRX)

  7. Chimerix Inc (CMRX) 뉴스

Chimerix Inc

Chimerix Inc (CMRX)

NASDAQ
8.455
0.005
( 0.06% )
업데이트: 02:10:18
15분 지연

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

프리미엄

CMRX 뉴스

공식 뉴스 전용

Form SC TO-C - Written communication relating to an issuer or third party
Edgar (US Regulatory)
06 3월 2025
CMRX (0.06%)

Form SC14D9C - Written communication relating to third party tender offer
Edgar (US Regulatory)
06 3월 2025
CMRX (0.06%)

Form 8-K/A - Current report: [Amend]
Edgar (US Regulatory)
06 3월 2025
CMRX (0.06%)

Form SC14D9C - Written communication relating to third party tender offer
Edgar (US Regulatory)
05 3월 2025
CMRX (0.06%)

Form 8-K - Current report
Edgar (US Regulatory)
05 3월 2025
CMRX (0.06%)

Form 8-K - Current report
Edgar (US Regulatory)
03 3월 2025
CMRX (0.06%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
15 2월 2025
CMRX (0.06%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
15 2월 2025
CMRX (0.06%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
15 2월 2025
CMRX (0.06%)

CMRX Discussion

게시물 보기
georgie18 georgie18 7 일 전
CMRX...$8.44...🥳...https://finance.yahoo.com/news/jazz-pharmaceuticals-bids-chimerix-935m-180335162.html
👍️0
glenn1919 glenn1919 1 주 전
CMRX....................................................................................p/m
👍️0
Monksdream Monksdream 1 주 전
CMRX, new 52 week high
👍️0
Monksdream Monksdream 3 주 전
CMRX new 52/week high
👍️0
glenn1919 glenn1919 2 월 전
CMRX................https://stockcharts.com/h-sc/ui?s=CMRX&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 2 월 전
cmrx...................https://stockcharts.com/h-sc/ui?s=cmrx&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 3 월 전
cmrx..................https://stockcharts.com/h-sc/ui?s=cmrx&p=W&b=5&g=0&id=p86431144783
👍️0
bikaver bikaver 3 월 전
CMRX.....bought in @ 2.93.....could see another leg up!
👍️0
glenn1919 glenn1919 3 월 전
CMRX.........................................https://stockcharts.com/h-sc/ui?s=CMRX&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 3 월 전
CMRX..............https://stockcharts.com/h-sc/ui?s=CMRX&p=W&b=5&g=0&id=p86431144783
🏦 1 ✅️ 1
Zardiw Zardiw 3 월 전
$CMRX - Gain: 217% #DDAmanda Video Analysis - #1 Stock Screener / Scanner

#DDAmanda Christmas Special Signup:

https://ddamanda.com/SignUpXMAS.php

Questions/Support: 760 702-2009 - Hans@DDAmanda.com



Z
👍️0
dablitz dablitz 3 월 전
Congrat's to those those who had a good day here today.
👍️0
Invest-in-America Invest-in-America 3 월 전
CMRX: Another article about it ---
https://finance.yahoo.com/news/why-cancer-focused-chimerix-stock-143934294.html
👍️0
georgie18 georgie18 3 월 전
CMRX...All out in the $3.10 range...🥳Beauty flip...from $2.02 range...

georgie18

Member Level
Re: georgie18 post# 667358

Tuesday, December 10, 2024 9:45:48 AM

Post#
667376
of 667379
CMRX...$2.71...🥳...Volume...Off my $2.02 Alert...

georgie18

Member Level
Re: georgie18 post# 386753

Tuesday, December 10, 2024 8:14:24 AM

Post#
386761
of 386773
CMRX...$2.37...🥳...Off my $2.02 Alert...

georgie18

Member Level
Re: georgie18 post# 667332

Monday, December 09, 2024 4:23:42 PM

Post#
667335
of 667357
CMRX...$2.22...🥳...

georgie18

Member Level
Re: None

Monday, December 09, 2024 4:21:32 PM

Post#
386753
of 386753
CMRX...$2.02...🥳...DURHAM, N.C., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX), a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that, following extensive dialogue with the U.S. Food and Drug Administration (FDA), the Company plans to submit a complete New Drug Application (NDA) seeking accelerated approval for dordaviprone as a treatment for recurrent H3 K27M-mutant diffuse glioma in the United States before year-end.
👍️0
georgie18 georgie18 3 월 전
CMRX...$2.71...🥳...Volume...Off my $2.02 Alert...

georgie18

Member Level
Re: georgie18 post# 386753

Tuesday, December 10, 2024 8:14:24 AM

Post#
386761
of 386773
CMRX...$2.37...🥳...Off my $2.02 Alert...

georgie18

Member Level
Re: georgie18 post# 667332

Monday, December 09, 2024 4:23:42 PM

Post#
667335
of 667357
CMRX...$2.22...🥳...

georgie18

Member Level
Re: None

Monday, December 09, 2024 4:21:32 PM

Post#
386753
of 386753
CMRX...$2.02...🥳...DURHAM, N.C., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX), a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that, following extensive dialogue with the U.S. Food and Drug Administration (FDA), the Company plans to submit a complete New Drug Application (NDA) seeking accelerated approval for dordaviprone as a treatment for recurrent H3 K27M-mutant diffuse glioma in the United States before year-end.
👍️0
georgie18 georgie18 3 월 전
CMRX...$2.37...🥳...Off my $2.02 Alert...

georgie18

Member Level
Re: georgie18 post# 667332

Monday, December 09, 2024 4:23:42 PM

Post#
667335
of 667357
CMRX...$2.22...🥳...

georgie18

Member Level
Re: None

Monday, December 09, 2024 4:21:32 PM

Post#
386753
of 386753
CMRX...$2.02...🥳...DURHAM, N.C., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX), a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that, following extensive dialogue with the U.S. Food and Drug Administration (FDA), the Company plans to submit a complete New Drug Application (NDA) seeking accelerated approval for dordaviprone as a treatment for recurrent H3 K27M-mutant diffuse glioma in the United States before year-end.
👍️0
glenn1919 glenn1919 3 월 전
CMRX.............................https://stockcharts.com/h-sc/ui?s=CRMX&p=W&b=5&g=0&id=p86431144783
👍️ 1 💲 1
Invest-in-America Invest-in-America 3 월 전
CMRX: Soaring!!! Likely $3-4 bucks in the Post-M!!!
👍️0
glenn1919 glenn1919 3 월 전
CMRX.......................https://stockcharts.com/h-sc/ui?s=CMRX&p=W&b=5&g=0&id=p86431144783
👍️0
georgie18 georgie18 3 월 전
CMRX...$2.22...🥳...

georgie18

Member Level
Re: None

Monday, December 09, 2024 4:21:32 PM

Post#
386753
of 386753
CMRX...$2.02...🥳...DURHAM, N.C., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX), a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that, following extensive dialogue with the U.S. Food and Drug Administration (FDA), the Company plans to submit a complete New Drug Application (NDA) seeking accelerated approval for dordaviprone as a treatment for recurrent H3 K27M-mutant diffuse glioma in the United States before year-end.
👍️0
georgie18 georgie18 3 월 전
CMRX...$2.02...🥳...DURHAM, N.C., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX), a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that, following extensive dialogue with the U.S. Food and Drug Administration (FDA), the Company plans to submit a complete New Drug Application (NDA) seeking accelerated approval for dordaviprone as a treatment for recurrent H3 K27M-mutant diffuse glioma in the United States before year-end.
👍 1
pzottkpz pzottkpz 4 월 전
⏰⏰⏰⏰⏰⏰⏰⏰⏰⏰

can this hold a buck if markets correct
or will they have to do something to maintain listing

💲CMRX
👍️0
Monksdream Monksdream 7 월 전
CMRX new 52 week low
👍️0
mick mick 2 년 전
GBIM
Globelmmune Inc (CE)
0.0002
0.00 (0.00%)
Volume:
👍️0
mick mick 2 년 전
GBIM
Globelmmune Inc (CE)
0.0002
0.00 (0.00%)
Volume:
👍️0
Monksdream Monksdream 2 년 전
CMRX new 52 low
👍️0
Monksdream Monksdream 2 년 전
CMRX new 52 week low
👍️0
Monksdream Monksdream 2 년 전
CMRX new 52 week low
👍️0
kzivann kzivann 2 년 전
Thanks, saw that but neglected to post news.

CMRX
👍️0
db7 db7 2 년 전
https://www.businesswire.com/news/home/20221110005658/en/
👍️0
kzivann kzivann 2 년 전
More good news.

CMRX
👍️0
kzivann kzivann 2 년 전
News looks good.

CMRX
👍️0
kzivann kzivann 3 년 전
Nice news. Got some.

CMRX
👍️0
weedtrader420 weedtrader420 3 년 전
WEEEEEEEEE
👍️0
weedtrader420 weedtrader420 3 년 전
Monday fun here CMRX$ WOW! Monkey pox vaccine
👍️0
weedtrader420 weedtrader420 3 년 전
$5 coming
👍️0
mcjodie mcjodie 3 년 전
Looking good
👍️0
weedtrader420 weedtrader420 3 년 전
CMRX$
👍️0
db7 db7 3 년 전
from the EBS earnings call transcript:

"
Unidentified Analyst

This is Nick on for Boris. So I just have a quick question about Chimerix and TEMBEXA. So previously, the -- right pretty much right after you guys announced this acquisition of TEMBEXA, they said that the BARDA contract was likely to take place within the next couple of weeks or months, and now it's pushed back. And I just wanted to know if you guys had any reasoning behind this or any information as to why it's been pushed back, especially with monkeypox and now being declared a public health emergency, you kind of think that it may be pushed forward, but it seems to be just pushed back a little bit more.

Bob Kramer

Yes. Thanks, Nick, for the question. Thanks for joining the call. So a couple of comments. As I commented on my prepared remarks, the HSR process and the waiting period for this expired last Friday. So now that, I think, gives BARDA and Chimerix kind of the green light to finalize the BARDA procurement agreement, which then gives us the clear path to closing the transaction and moving forward.

I wouldn't read anything into the perhaps perceived delay in getting the contract awarded. Obviously, BARDA is looking at this very carefully and they are aware that our interest in acquiring the product from Chimerix. So I think, again, there's momentum to get this done, and we're anxious to get done as well

"
👍️0
db7 db7 3 년 전
my hope is that the BARDA negotiation is to 'upsize' the original contract that was discussed(?)
👍️0
weedtrader420 weedtrader420 3 년 전
CMRX$$$$$$$$ WOOHOOOOOO
👍️0
weedtrader420 weedtrader420 3 년 전
CMRX$ $5 TARGET
👍️0
weedtrader420 weedtrader420 3 년 전
CMRX$Surfin USA
👍️0
db7 db7 3 년 전
interesting if we get BARDA announcement this week; per last extension due 'soon'
👍️0
Trend22 Trend22 3 년 전
CMRX - Nice news and nice pre market!
👍️0
weedtrader420 weedtrader420 3 년 전
CMRX$
👍️0
weedtrader420 weedtrader420 3 년 전
CMRX SIGA $$$$$$$$$$$$
👍️0
weedtrader420 weedtrader420 3 년 전
CMRX$
👍️0
weedtrader420 weedtrader420 3 년 전
Now we’re moving WOOHOOOOOO CMRX$$$$$$$$$$$$$$SIGA
👍️0
weedtrader420 weedtrader420 3 년 전
CMRX SIGA Upchurch HI-DEAS 2 $$$$$$$$$$$
👍️0

최근 히스토리

NASDAQ
CMRX
Chimerix
TG
A254PW
E.ON
BIT
UIC091
UniCredit Bank
BIT
UC7T5W
Unicredit Bank
BIT
UC6SQ2
Unicredit Bank
BIT
P130F9
BNP PARIBAS ISSUANCE
BIT
UC20QF
Unicredit Bank
BIT
UC2BX6
Unicredit Bank
BIT
SJPA
Exchange Trading Funds
BIT
NSCIT0132505
Republic of France
BIT
GS0274
Goldman Sachs
BIT
EIB5
Invesco Euro Government ...
BIT
UI375C
Unicredit Bank
BIT
UC6SPZ
Unicredit Bank
BIT
F25251
Vontobel Financial Produ...
TG
IRUG
BlackRock Institutional ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지